Cargando…

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)

Background: Oxysterol relationship with cardiovascular (CV) risk factors is poorly explored, especially in moderately hypercholesterolaemic subjects. Moreover, the impact of nutraceuticals controlling hypercholesterolaemia on plasma levels of 24-, 25- and 27-hydroxycholesterol (24-OHC, 25-OHC, 27-OH...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicolari, Stefania, Pavanello, Chiara, Olmastroni, Elena, Puppo, Marina Del, Bertolotti, Marco, Mombelli, Giuliana, Catapano, Alberico L., Calabresi, Laura, Magni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911956/
https://www.ncbi.nlm.nih.gov/pubmed/33525601
http://dx.doi.org/10.3390/nu13020427
_version_ 1783656463732834304
author Cicolari, Stefania
Pavanello, Chiara
Olmastroni, Elena
Puppo, Marina Del
Bertolotti, Marco
Mombelli, Giuliana
Catapano, Alberico L.
Calabresi, Laura
Magni, Paolo
author_facet Cicolari, Stefania
Pavanello, Chiara
Olmastroni, Elena
Puppo, Marina Del
Bertolotti, Marco
Mombelli, Giuliana
Catapano, Alberico L.
Calabresi, Laura
Magni, Paolo
author_sort Cicolari, Stefania
collection PubMed
description Background: Oxysterol relationship with cardiovascular (CV) risk factors is poorly explored, especially in moderately hypercholesterolaemic subjects. Moreover, the impact of nutraceuticals controlling hypercholesterolaemia on plasma levels of 24-, 25- and 27-hydroxycholesterol (24-OHC, 25-OHC, 27-OHC) is unknown. Methods: Subjects (n = 33; 18–70 years) with moderate hypercholesterolaemia (low-density lipoprotein cholesterol (LDL-C:): 130–200 mg/dL), in primary CV prevention as well as low CV risk were studied cross-sectionally. Moreover, they were evaluated after treatment with a nutraceutical combination (Bifidobacterium longum BB536, red yeast rice extract (10 mg/dose monacolin K)), following a double-blind, randomized, placebo-controlled design. We evaluated 24-OHC, 25-OHC and 27-OHC levels by gas chromatography/mass spectrometry analysis. Results: 24-OHC and 25-OHC were significantly correlated, 24-OHC was correlated with apoB. 27-OHC and 27-OHC/total cholesterol (TC) were higher in men (median 209 ng/mL and 77 ng/mg, respectively) vs. women (median 168 ng/mL and 56 ng/mg, respectively); 27-OHC/TC was significantly correlated with abdominal circumference, visceral fat and, negatively, with high-density lipoprotein cholesterol (HDL-C). Triglycerides were significantly correlated with 24-OHC, 25-OHC and 27-OHC and with 24-OHC/TC and 25-OHC/TC. After intervention, 27-OHC levels were significantly reduced by 10.4% in the nutraceutical group Levels of 24-OHC, 24-OHC/TC, 25-OHC, 25-OHC/TC and 27-OHC/TC were unchanged. Conclusions: In this study, conducted in moderate hypercholesterolemic subjects, we observed novel relationships between 24-OHC, 25-OHC and 27-OHC and CV risk biomarkers. In addition, no adverse changes of OHC levels upon nutraceutical treatment were found.
format Online
Article
Text
id pubmed-7911956
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79119562021-02-28 Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study) Cicolari, Stefania Pavanello, Chiara Olmastroni, Elena Puppo, Marina Del Bertolotti, Marco Mombelli, Giuliana Catapano, Alberico L. Calabresi, Laura Magni, Paolo Nutrients Article Background: Oxysterol relationship with cardiovascular (CV) risk factors is poorly explored, especially in moderately hypercholesterolaemic subjects. Moreover, the impact of nutraceuticals controlling hypercholesterolaemia on plasma levels of 24-, 25- and 27-hydroxycholesterol (24-OHC, 25-OHC, 27-OHC) is unknown. Methods: Subjects (n = 33; 18–70 years) with moderate hypercholesterolaemia (low-density lipoprotein cholesterol (LDL-C:): 130–200 mg/dL), in primary CV prevention as well as low CV risk were studied cross-sectionally. Moreover, they were evaluated after treatment with a nutraceutical combination (Bifidobacterium longum BB536, red yeast rice extract (10 mg/dose monacolin K)), following a double-blind, randomized, placebo-controlled design. We evaluated 24-OHC, 25-OHC and 27-OHC levels by gas chromatography/mass spectrometry analysis. Results: 24-OHC and 25-OHC were significantly correlated, 24-OHC was correlated with apoB. 27-OHC and 27-OHC/total cholesterol (TC) were higher in men (median 209 ng/mL and 77 ng/mg, respectively) vs. women (median 168 ng/mL and 56 ng/mg, respectively); 27-OHC/TC was significantly correlated with abdominal circumference, visceral fat and, negatively, with high-density lipoprotein cholesterol (HDL-C). Triglycerides were significantly correlated with 24-OHC, 25-OHC and 27-OHC and with 24-OHC/TC and 25-OHC/TC. After intervention, 27-OHC levels were significantly reduced by 10.4% in the nutraceutical group Levels of 24-OHC, 24-OHC/TC, 25-OHC, 25-OHC/TC and 27-OHC/TC were unchanged. Conclusions: In this study, conducted in moderate hypercholesterolemic subjects, we observed novel relationships between 24-OHC, 25-OHC and 27-OHC and CV risk biomarkers. In addition, no adverse changes of OHC levels upon nutraceutical treatment were found. MDPI 2021-01-28 /pmc/articles/PMC7911956/ /pubmed/33525601 http://dx.doi.org/10.3390/nu13020427 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cicolari, Stefania
Pavanello, Chiara
Olmastroni, Elena
Puppo, Marina Del
Bertolotti, Marco
Mombelli, Giuliana
Catapano, Alberico L.
Calabresi, Laura
Magni, Paolo
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title_full Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title_fullStr Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title_full_unstemmed Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title_short Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
title_sort interactions of oxysterols with atherosclerosis biomarkers in subjects with moderate hypercholesterolemia and effects of a nutraceutical combination (bifidobacterium longum bb536, red yeast rice extract) (randomized, double-blind, placebo-controlled study)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911956/
https://www.ncbi.nlm.nih.gov/pubmed/33525601
http://dx.doi.org/10.3390/nu13020427
work_keys_str_mv AT cicolaristefania interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT pavanellochiara interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT olmastronielena interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT puppomarinadel interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT bertolottimarco interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT mombelligiuliana interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT catapanoalbericol interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT calabresilaura interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy
AT magnipaolo interactionsofoxysterolswithatherosclerosisbiomarkersinsubjectswithmoderatehypercholesterolemiaandeffectsofanutraceuticalcombinationbifidobacteriumlongumbb536redyeastriceextractrandomizeddoubleblindplacebocontrolledstudy